论文部分内容阅读
江苏扬子江药业集团公司始创于 1971年 ,是国家重点扶植和支持的、以高新技术为支撑的大型医药企业集团 ,集团设有博士后科研工作站 ,国家级技术中心和全国最大的中药提取生产基地 ,综合经济效益已连续三年在全国 6 0 0 0多家制药企业中排名前五位。在中国“入世”即将圆梦的时刻 ,该集团确立走中药现代化、国际化的发展道路 ,以技术创新为先导 ,未雨绸缪 ,迎接WTO的挑战。
Founded in 1971, Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. is a large-scale pharmaceutical enterprise group supported and supported by the country and supported by high technology. The group has a post-doctoral research station, a state-level technology center and the country’s largest extraction and production base for traditional Chinese medicine. The comprehensive economic efficiency has been ranked in the top five among more than 600 pharmaceutical companies nationwide for three consecutive years. At the moment when China’s accession to the WTO is about to realize its dreams, the group has established the path of modernization and internationalization of Chinese medicine, taking technological innovation as a guide and taking precautions to meet the challenges of the WTO.